Theriva Biologics Inc (AMEX:TOVX) traded at $2.07 at close of the session on Monday, November 04 and made an upward move of 4.02% on its previous day’s price.
Looking at the stock we see that its previous close was $1.99 and the beta (5Y monthly) reads 1.35 with the day’s price range being $1.745 – $2.08. In terms of its 52-week price range, TOVX has a high of $17.11 and a low of $1.24. The company’s stock has gained about 23.21% over that past 30 days.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Theriva Biologics Inc has a market cap of $6.41 million and is expected to release its quarterly earnings report in December.
On the other hand, looking at the outlook for the TOVX stock, short term indicators assign the stock an average of 50% Sell, while medium term indicators assign it an average of 100% Sell.
Looking further, we note the current price level is 34.18% off its SMA20 and -18.55% from its 50-day simple moving average. The RSI (14) is pointing at 55.51 while the volatility over the past week is 17.77% and jumps to 10.12% over the past one month. The beta value is 1.32, while the average true range (ATR) is currently pointing at 0.29.
Coming back to Theriva Biologics Inc (AMEX:TOVX), we note that the average 3-month trading volume was 3.29 million, while that of the preceding 10-day period stands at 8.97 million. Current shares outstanding are 2.27 million.
The insiders hold 2.14% of the company’s shares while institutions hold 32.46%. The data shows that short shares as of 2024-10-15, stood at 79011.0 at a short ratio of 0.02. This represents a 349.00 short interest in shares outstanding on 2024-10-15. Shares short fall in October from the previous month at 90984.0. Investors should be excited about this stock as its upside potential is great, with current price pushing the stock -80.75% down in year-to-date price movement.
